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running sutures include several primary and secondary 
chordae, facilitating a more even distribution of tension 
among many chordae. Simultaneously, it makes it possible 
to correct any interchordal prolapse (redundancy between 
adjacent chordal insertions) resulting in a uniform free 
edge remodeling and a better leaflet coaptation, which 
seems to reduce the tension on the chordae. 6 Finally, our 
technique leaves the papillary muscle intact. 
Our experience with the technique of chordal suture 
plication and free edge remodeling in patients with ante- 
rior leaflet prolapse without chordal rupture suggests that 
chordal shortening can be as effective as chordal transfer 
at midterm. This technique is more straightforward than 
other shortening techniques and makes it possible to keep 
the posterior leaflet intact in the absence of prolapse, as in 
10 (32.3%) of our 31 Patients. A larger number of 
patients, however, and a longer follow-up are required to 
confirm our results. 
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Effect of preoperative antioxidant supplements on 
perioperative myocardial injury 
To the Editor." 
We read with great interest the article "Effect of 
Preoperative Supplementation With a-Tocopherol and 
Ascorbic Acid on Myocardia ! Injury in Patients Under- 
going Cardiac Operations," by Westhuyzen and associ- 
ates. 1 We fully agree with the concept of ischemia- 
reperfusion injury to the myocardium and the 
mechanism ost likely to be associated with thatphe- 
nomenon (e.g., oxygen-derived free radical generation 
and subsequent cell membrane lipid peroxidation i jury 
and microvascular injury). The supplementation of 
water-soluble and lipid-soluble antioxidant micronutri- 
ents in this study was found not to have had much 
differential effect (versus p lacebo)on the hard end 
points of irreversible injury in the subgroup of 36 
patients; in a study of this size, one may not anticipate 
such a difference, if present, to be demonstrable. How- 
ever, the methods of using hard end points of irrevers- 
ible myocard!al injury (creatine kinase MB isoenzyme 
levels, electrocardiographic QRS scores, and thallium 
single photon emission computed tomography defects) 
seem unsuited to detect more subtle, sublethal, func- 
tional end points of injury that are classically associated 
with myocardial stunning. Functional end points, such 
as requirement for inotropic agents, ejection-phase 
indices of myocardial performance, or hemodynamic 
outcome were not published. Lipid peroxidation prod- 
ucts in coronary sinus effluent were not measured; this 
technique might have been a more sensitive instrument 
to measure clinically relevant differences in the antiox- 
idant protective effect of c~-tocopherol and ascorbic 
acid. 
Postischemic perioperative myocardial injury may 
take the form of myocardial infarction or necrosis with 
the typical enzyme leak and electrocardiographic 
changes, or it may be the result of sublethal injury as 
described in "myocardial stunning. ''2 After an ischemic 
event and during reperfusion, superoxide anion, hydro- 
gen peroxide, and the hydroxyl radical induce lipid 
peroxidation; these injuries cause either a transient 
calcium overload-induced proteolysis of myofilament 
contractile proteins or a direct peroxidation injury to 
myofilament protein (or both) during myocardial stun- 
ning. Cellular viability is maintained, and electrocardio- 
graphic changes and creatine kinase isoenzyme leak are 
typically absent, thus separating myocardial stunning 
from necrosis. The cellular extraction of thallium 201 is 
unaffected by hypoxia unless irreversible injury is 
present) Also, pathophysiologic conditions of chronic 
hypoperfusion (hibernating myocardium) and postisch- 
emic dysfunction (stunned myocardium), in which re- 
gional contractile function is impaired in the presence 
of myocardial viability, do not adversely alter extraction 
of thallium 201. 3, 4 Therefore the absence of a demon~ 
strable difference between antioxidant Supplements an d 
placebo in regar d to the postoperative thallium 201 
SPECT scan defects does not exclude a meaningful 
beneficial effect on  myocardial stunning. Coronary si- 
nus plasma levels of hydrogen peroxide, the nonspecific 
lipid peroxidadon marker malondialdehyde, and hy- 
droxy-conjugated diene fatty acids would provide a 
more sensitive tool to determine a protective ffect of 
antioxidant supplemental therapy against stunning than 
would peripheral plasma creatine kinase MB isoenzym e 
levels~ We are in agreement hat the study design 
excluded a subpopulati0n of patients who may have 
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demonstrated a more clinically relevant and statistically 
significant difference, that is, patients with depresse d 
systolic function who require a more prolonged period 
of cardioplegic ischemic arrest. The findings of their 
study are without dispute; the population studied and 
the tools with which they were studied could have been 
chosen differently to determine the true effect of anti- 
oxidant supplementation sublethal myocardial injury 
in patients undergoing cardioplegic ischemic arrest. 
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Reply to the Editor." 
We thank Drs. Wait and Grayburn for their interest and 
for raising the important question of sublethal myocardial 
injury in patients undergoing cardioplegic schemic arrest. 
We used clinically important markers of irreversible myo- 
cardial injury to determine the antioxidant protective 
effect of c~-tocopherol and ascorbic acid, and we did not 
specifically examine the possibility of a beneficial but 
lesser effect on functional impairment ("stunning"). How- 
ever~ there are very few "perfect" measures of postoper- 
ative function and many are open to one criticism or 
another. The inotropic requirement is a "soft" measure 
and can vary markedly depending on the concomitant 
degree of volume administered, the depth of anesthesia or 
postoperative s dation, and the particular guidelines for 
blood pressure and filling pressures regarded as accept- 
able in that hospital. In fact, very few patients in this study 
required any inotropic support in the postoperative pe- 
riod. 
We agree that further studies should look for more 
subtle effects; however, if the antioxidant effects are small 
and transient, he clinical benefit of treatment may be only 
marginal. 
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Should intraaortic balloon counterpulsation be 
continued during cardiopulmonary bypass? 
To the Editor: 
We read with interest the article by Torchiana and 
associates 1 in the April 1997 issue of this Journal regard- 
ing trends in practice and outcome of intraaortic balloon 
(IAB) pumping for cardiac support. Using the strategy of 
preoperative insertion of the lAB, several other groups 
have also shown improvement in survival and reduced 
morbidity from perioperative infarction. 2-4 In many cen- 
ters an IAB is now electively inserted in the preoperative 
period for indications uch as evolving myocardial infarc- 
tion, refractory unstable angina, failed percutaneous 
transluminal ngioplasty necessitating emergency myocar- 
dial revascularization, complication of myocardial infarc- 
tion with cardiogenic shock, or redo operations. 3-5 Very 
little, however, is mentioned about the continuation of 
IAB counterpulsation during cardiopulmonary bypass 
(CPB). If an IAB has to be inserted before the cardiac 
operation is begun, we prefer to continue counterpulsa- 
tion throughout the operation. Counterpulsation is con- 
tinued even during the period of aortic crossclamping on 
th e intrinsic rate of the IAB and with 20% less than full 
augmentation. Once the heart starts ejecting, IAB coun- 
terpulsation can be synchronized with left ventricular 
diastole , unlike counterpulsation with conventional pulsa- 
tile pumps, to augment diastolic pumping and decrease 
systolic impedance. We temporarily stop the IAB pump 
only when clamping or unclamping the aorta. 
Many surgeons top IAB counterpulsation as soon as 
CPB is resumed, and counterpulsation is restarted while 
weaning the patient from CPB. We sent a questionnaire to
46 centers performing adult cardiac surgery in the United 
Kingdom and Ireland. From the 36 replies (78.2%) that 
we received, all surgeons at 29 centers (80.5%) stop IAB 
counterpu!sation  commencing CPB. At one center the 
IAB pump is set on minimum volume and frequency, 
mainly to reduce the risk of clotting. At the remaining six 
centers counterpulsation is continued uring CPB by all 
surgeons except one. It seems that not many surgeons 
make use of the potential advantages of having the IAB 
already in situ during CPB. 
IAB counterpulsation effectively minimizes ischemic 
myocardia 1 damage during induction of general anesthe- 
sia and during the pre-CPB period while conduits are 
being harvested, z' 6 On initiation of CPB, systemic perfu- 
sion is maintained with reduced pre!oad, which reduces 
myocardial oxygen needs significantly. The use of IAB 
